Products

Finished Dosage Forms

  • CEFACLOR CAPSULES: 250 mg | 500 mg
  • CEFACLOR MODIFIED RELEASE TABLETS: 375 mg | 500 mg | 750 mg
  • CEFACLOR ORAL SUSPENSION: 125 mg/5 ml | 187 mg/5 ml | 250 mg/5 ml | 375 mg/5 ml
  • CEFACLOR TABLETS: 250 mg | 500 mg
  • CEFADROXIL CAPSULES: 250 mg | 500 mg
  • CEFADROXIL ORAL SUSPENSION: 250 mg/5 ml | 500 mg/5 ml
  • CEFIXIME CAPSULES: 400 mg
  • CEFIXIME COATED TABLETS: 400 mg
  • CEFIXIME DISPERSIBLE TABLETS: 400 mg
  • CEFIXIME ORAL SUSPENSION: 100 mg/5 ml
  • CEFPROZIL ORAL SUSPENSION: 125 mg/5 ml
  • CEFRADINE CAPSULES: 250 mg | 500 mg
  • CEFTIBUTEN CAPSULES: 400 mg
  • CEFTIBUTEN ORAL SUSPENSION: 36 mg/ml
  • CEPHALEXIN CAPSULES: 250 mg | 500 mg
  • CEPHALEXIN ORAL SUSPENSION: 125 mg/5 ml | 250 mg/5 ml
  • CEPHALEXIN TABLETS: 250 mg | 500 mg | 1 g
  • SULOPENEM TABLETS (on exclusive basis)

 

It is the customer’s responsibility to verify the patent status in the relevant country. Our offer is subject to final confirmation.

  • AMPICILLIN AND SULBACTAM FOR INJECTION: 1,5 g/vial | 3 g/vial | 15 g/vial
  • AMPICILLIN FOR INJECTION: 500 mg/vial | 1 g/vial | 2 g/vial | 10 g/vial 
  • CEFAZOLIN FOR INJECTION: 500 mg/vial | 1 g/vial | 10 g/vial
  • CEFEPIME FOR INJECTION: 1 g/vial | 2 g/vial
  • CEFOTAXIME FOR INJECTION: 250 mg/vial | 500 g/vial | 1 g/vial | 2 g/vial
  • CEFOTETAN FOR INJECTION (US ONLY): 1 g/vial | 2 g/vial
  • CEFOXITIN FOR INJECTION:  1 g/vial | 2 g/vial | 10 g/vial
  • CEFTAROLINE FOR INJECTION (on exclusive basis): 400 mg e 600 mg
  • CEFTALOZANE AND TAZOBACTAM (ON EXCLUSIVE BASIS)
  • CEFTAZIDIME+AVIBACTAM (on exclusive basis): 2g + 500mg (unique dosage)
  • CEFTAZIDIME FOR INJECTION: 250 mg/vial |500 mg/vial | 1 g/vial | 2 g/vial | 6 g/vial
  • CEFTRIAXONE FOR INJECTION: 250 mg/vial | 500 mg/vial | 1 g/vial | 2 g/vial | 10 g/vial
  • CEFUROXIME FOR INJECTION: 50 mg/vial | 250 mg/vial | 500 mg/vial | 750 mg/vial | 1 g/vial | 2 g/vial | 1,5 g/vial
  • CEPHALOTIN FOR INJECTION: 1 g/vial | 2 g/vial
  • CLINDAMYCIN FOR INJECTION: 300 mg/2 ml | 600 mg/4 ml
  • CLOXACILLIN FOR INJECTION: 1 g/vial | 2 g/vial
  • ERTAPENEM FOR INJECTION: 1 g/vial
  • IMIPENEM AND CILASTATIN FOR INJECTION: 250+250 mg/vial | 500+500 mg/vial
  • MEROPENEM FOR INJECTION: 500 mg/vial | 1 g/vial | 2 g/vial
  • PENICILLIN FOR INJECTION: 5 milion u/vial | 20 milion u/vial
  • PIPERACILLIN FOR INJECTION: 1 g/vial | 2 g/vial | 3 g/vial | 4 g/vial
  • PIPERACILLIN – TAZOBACTAM: 2,25 g/vial | 3,375 g/vial | 4,5 g/vial

 

It is the customer’s responsibility to verify the patent status in the relevant country. Our offer is subject to final confirmation.

  • CEFAZOLIN FOR INJIECTION: 100 g e 300 g
  • CEFUROXIME FOR INJECTION: 75 g e 225 g
  • CEFEPIME FOR INJECTION: 100 g
  • CEFTRIAXONE FOR INJECTION: 100 g e 300 g
  • CEFOXITIN FOR INJECTION: 100 g
  • PIPERACILLINA AND TAZOBACTAM: 225 g
  • VANCOMYCIN FOR INJECTION: 100 g

System benefits

  • Dramatically reduces potential for medication errors
  • Traceability
  • No glass means no breakage
  • Complete safety for the operators
  • Few operative steps
  • Reduction of contamination risks
  • A totally closed system
  • Maximum sterility
  • Less material wastage
  • Cost reduction

It is the customer’s responsibility to verify the patent status in the relevant country. Our offer is subject to final confirmation.

Download Minibags Product List

 

It is the customer’s responsibility to verify the patent status in the relevant country. Our offer is subject to final confirmation.